Taking aspirin may protect against colorectal cancer in people at risk, a study published in the journal Cancer Research suggests. JAMA Oncology.
Scientists analyzed data from 107,000 patients. The 10-year incidence of colorectal cancer was 1.98% in the regular aspirin group and 2.95% in the other group. Regular aspirin use was defined as taking a certain dose of the drug.
Those with the unhealthiest lifestyles benefited the most from the drug. Their risk of colorectal cancer was 3.4% if they did not take aspirin, compared with 2.12% if they did. This means that taking aspirin would have prevented 1 in 78 cases of colorectal cancer in the unhealthy lifestyle group over 10 years. Those with a healthy lifestyle benefited the least. Taking aspirin would have prevented only 1 in 909 cases of colorectal cancer. Lifestyle points were given for a healthy weight, no nicotine addiction, minimal or no alcohol consumption, good nutrition, and physical activity.
Previous studies have shown that aspirin prevents colorectal cancer through a variety of mechanisms. For this reason, the United States recommended daily low-dose aspirin for everyone ages 50 to 59 to prevent cardiovascular events and colorectal cancer. This recommendation was rescinded in 2016 due to concerns that aspirin increases the risk of gastrointestinal bleeding. The new study did not assess bleeding risk but was able to identify groups that may benefit most from aspirin. Future studies should focus on these.
Previously a cardiologist It has been saidFor whom is aspirin contraindicated?
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.